Voglistar GM1 Tablet ER
By Voglistar GM
Rx
15 Tablet ER in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
September, 2025

liver
When using Voglistar GM1 Tablet ER, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication. It's recommended to consult your doctor before starting treatment. Typically, Voglistar GM1 Tablet ER is initiated at a low dose for individuals with mild to moderate liver disease. However, it is advised not to use this medication in patients with severe liver disease. It's essential to prioritize your liver health and seek guidance from a healthcare professional when considering the use of Voglistar GM1 Tablet ER.

kidney
Voglistar GM1 Tablet ER may not be safe for patients with kidney disease and should be avoided. Consult your doctor before using. Not recommended for those with severe kidney issues.

alcohol
It is risky to drink alcohol with Voglistar GM1 Tablet ER.

driving
When taking Voglistar GM1 Tablet ER, avoid driving if experiencing low or high blood sugar symptoms that may affect your focus or reaction time.

pregnancy
Voglistar GM1 Tablet ER may be unsafe during pregnancy, as animal studies suggest possible harm to the developing baby. Your doctor will assess potential risks and benefits before prescribing. Please consult your doctor.

breastfeeding
Voglistar GM1 Tablet ER may not be safe to use while breastfeeding as it can possibly pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹223.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024